Cephalopelvic Disproportion (CPD)

Cephalopelvic Disproportion (CPD): Causes, Clinical Signs and Diagnosis 

0
0

Estimated reading time: 7 minutes

Labour room cases can be challenging, especially when labour is not progressing as expected. As an OBG resident, knowing when to suspect a problem and how to assess it clinically is an important part of your training. One such condition is cephalopelvic disproportion (CPD), which can affect the progress of labour and influence decisions about delivery. 

In this blog, we will discuss the causes and risk factors of CPD, the clinical signs of obstructed labour, how CPD is assessed and the important points of the Müller–Munro Kerr method. These concepts are useful for your OBG theory exams, viva and clinical learning during residency. 

What Is Cephalopelvic Disproportion (CPD)? 

In labor, the baby’s head has to pass through the mother’s pelvis to be born vaginally. But sometimes the size or shape of the fetal head and maternal bony pelvis are incompatible. This is called cephalopelvic disproportion (CPD). 

CPD is an important subject for postgraduate trainees in Obstetrics and Gynecology (OBG), not only for exams but also in clinical decision making in the labor room. 

Causes and Risk Factors of CPD 

Several factors can contribute to cephalopelvic disproportion. These include: 

  • Maternal factors: Abnormal pelvic development, previous pelvic injury or disease, and short maternal stature. 
  • Fetal factors: A large baby, suspected fetal macrosomia and an unfavourable fetal position. 
  • Pregnancy-related factors: Maternal diabetes may increase the risk of a large baby. Post-term pregnancy and polyhydramnios may also require closer assessment. 

Maternal height below 145 cm is sometimes considered a clinical clue, but height alone cannot confirm CPD. 

Having one or more risk factors does not automatically mean that vaginal delivery will be difficult. The patient’s clinical condition and progress of labour are equally important. 

Clinical Signs of Obstructed Labour 

Recognising abnormal labour progress is essential when CPD is suspected. Obstruction may occur at the pelvic inlet, mid-pelvis or outlet. 

Maternal signs include: 

  • Exhaustion and dehydration 
  • Tachycardia 
  • Marked distension of the urinary bladder 
  • Features of metabolic disturbance in severe cases 

A distended bladder needs particular attention during obstructed labour. Prolonged pressure on the bladder and surrounding tissues may cause tissue damage and increase the risk of complications such as vesicovaginal fistula (VVF). 

Fetal signs include: 

  • Failure of the fetal head to descend 
  • Excessive caput succedaneum 
  • Excessive moulding of the fetal head 
  • Fetal distress 
  • Bandl’s ring in advanced obstructed labour 

These findings require careful assessment because delayed recognition of obstructed labour can put both mother and baby at risk. 

When Should CPD Be Suspected During Labour? 

Sometimes, labour does not progress as expected, even when the mother is having regular contractions. In such situations, cephalopelvic disproportion (CPD) should be considered, especially when the baby’s head is not moving down through the birth canal. 

Here are some important signs to look for during labour: 

  1. The fetal head does not engage: This may raise suspicion, particularly in a first pregnancy, depending on the stage of labour and the clinical findings. 
  1. Cervical dilatation is slow: The cervix takes longer to dilate, even when contractions are adequate. 
  1. Cervical dilatation stops: Labour progress comes to a halt instead of continuing as expected. 
  1. Excessive caput and moulding: Swelling of the fetal scalp or overlapping of the skull bones may be seen, especially when the head is not descending. 
  1. Fetal distress: Changes in the baby’s condition need prompt assessment and appropriate management. 

These signs should always be assessed together rather than considered proof of CPD on their own. The decision about further management depends on the progress of labour, the mother’s condition, the baby’s wellbeing and established clinical criteria. 

The priority is not simply to achieve a normal vaginal delivery, but to make the safest decision for both mother and baby. 
 
Watch Video: Cephalopelvic Disproportion (CPD) | Causes, Clinical Signs, Diagnosis & Rothera–Müller Method 

Diagnosis of Cephalopelvic Disproportion 

The diagnosis of CPD involves clinical assessment and investigations when indicated. 

1. Abdominal examination 

This helps assess fetal lie, presentation, engagement, descent and estimated fetal weight. Clinical estimation of fetal weight is an important skill for OBG residents, although it is not exact. 

2. Vaginal examination 

Vaginal examination helps assess cervical dilatation, fetal station and position, caput and moulding. These findings should be considered alongside the overall progress of labour. 

3. Clinical pelvimetry 

Clinical pelvimetry involves assessing the maternal pelvis for features that may suggest pelvic inadequacy. It is performed when clinically indicated. 

4. Imaging 

Ultrasound helps assess fetal growth and presentation. MRI or other imaging may be considered in selected cases. However, imaging alone cannot reliably determine whether vaginal delivery will be successful. 

Müller–Munro Kerr Method 

The Müller–Munro Kerr method is an important topic in OBG clinical teaching and examination preparation. The method described in the lecture assesses the relationship between the fetal head and the maternal pubic symphysis. 

The main principle is to assess whether the fetal head can be guided down into the pelvis and whether there is overriding of the parietal bones over the pubic symphysis. 

The findings described in the lecture can be summarised as follows: 

  • No significant overriding: The head can be guided down without significant overriding, making major CPD less likely on this assessment. 
  • Possible minor CPD: The head does not descend as expected, and the parietal bone is approximately level with the pubic symphysis. 
  • Possible major CPD: The head cannot be guided down, with marked overriding over the pubic symphysis. 

These findings must be correlated with the complete clinical examination. The method should not be used alone to confirm or exclude CPD. 

For examinations, make sure you understand the principle, anatomical landmarks and interpretation of the findings. 

Important Clinical Takeaways for OBG Residents 

While revising cephalopelvic disproportion, keep these points in mind: 

  • CPD involves a mismatch between the fetal head and maternal bony pelvis. 
  • Risk factors help guide assessment but do not establish the diagnosis. 
  • Poor descent, arrested cervical dilatation and excessive moulding may indicate abnormal labour progress. 
  • Maternal exhaustion, bladder distension and fetal distress need careful attention. 
  • Clinical pelvimetry and the Müller–Munro Kerr method are relevant topics for OBG theory and viva preparation. 
  • Timely intervention should be based on labour progress, maternal and fetal wellbeing, and established guidelines. 

Conclusion 

Cephalopelvic disproportion is an important topic in obstetric practice because it can contribute to obstructed labour and serious complications if not recognised in time. 

For OBGYN residents, understanding its causes, clinical signs and assessment methods is essential for both examinations and clinical practice. Careful observation, sound clinical judgement and timely decisions help obstetricians provide safer care to mothers and babies. 

Frequently Asked Questions 

Ques1: What are the common signs of CPD during labour? 

Ans1: Poor descent of the fetal head, slow or arrested cervical dilatation, excessive moulding and caput may raise suspicion. 

Ques2: How is CPD diagnosed? 

Ans2: Assessment includes abdominal and vaginal examinations, evaluation of labour progress and selected investigations when indicated. 

Ques3: Why is the Müller–Munro Kerr method important? 

Ans3: It is discussed in OBG teaching for assessing the relationship between the fetal head and maternal pelvis and is useful for clinical examination preparation. 

Continue Your OBG Residency Learning with Conceptual OBG 

Looking for more insightful sessions, expert-led lectures and reliable study materials for your residency? 

Conceptual OBG offers learning resources and clinical discussions to help you build your knowledge throughout your Obstetrics and Gynaecology residency. 

Download the eConceptual app and subscribe to Conceptual OBG to explore more relevant lectures, insightful sessions and study materials for your residency journey. 

Share

Dr Aditya Nimbkar

Must Watch Topic for NEET SS: Predictors and Future of Preeclampsia – Explained Simply By Dr. Aditya Nimbkar

0
0

Estimated reading time: 4 minutes

Preeclampsia is something every OBG resident sees almost every day. Honestly, it’s so common that we sometimes forget how serious it actually is. In India, the numbers are worrying. Roughly one in every 10 to 20 pregnant women develops preeclampsia. That means almost every clinic or ward has multiple such patients.

What’s frustrating is this — even after so many years of research, and despite India being a high-risk population, we still struggle with predicting and preventing preeclampsia effectively. This session by Dr. Aditya Nimbkar focuses exactly on that: what we can predict today, what we can actually do, and where the future might be headed.

What Exactly Is Preeclampsia?

By definition, preeclampsia means:

  • Blood pressure more than 140/90 mmHg
  • Recorded on two occasions, at least 4 hours apart
  • After 20 weeks of pregnancy

That part is basic, and everyone knows it. But the real issue is not diagnosis.
The real issue is prediction.

Why Does Preeclampsia Happen?

The core problem starts very early in pregnancy.

Normally, trophoblasts invade the spiral arterioles. This invasion destroys the tunica layers and converts high-resistance vessels into low-resistance ones. This change is necessary because pregnancy needs more blood flow to the placenta and fetus.

When this trophoblastic invasion is faulty:

  • Blood flow to the placenta reduces
  • Placental hypoxia develops
  • The whole disease process begins
Angiogenic vs Anti-Angiogenic Factors

Placental hypoxia leads to increased anti-angiogenic factors, mainly:

  • sFlt-1
  • Soluble endoglin

At the same time, pro-angiogenic factors reduce:

  • Placental Growth Factor (PLGF)
  • VEGF

Simply put:

  • Less PLGF
  • More sFlt-1
    = higher risk of preeclampsia
PLGF Levels – Why They Matter

PLGF is one of the most useful markers we have today.

  • PLGF > 100 → risk of preeclampsia is very low
  • PLGF < 33 → very high chance of developing preeclampsia later

The lower the PLGF, the worse the placental function.

sFlt-1 / PLGF Ratio – Short-Term Prediction

This ratio helps predict what may happen in the next 1–2 weeks.

  • Before 34 weeks
    • Ratio > 85
    • High risk of severe preeclampsia, eclampsia, or abruption
  • Between 34–37 weeks
    • Ratio > 110
    • Again, there is a high risk of serious events soon

The cut-offs differ because PLGF and sFlt-1 levels behave differently as pregnancy advances.

Is This Test Really Useful?

Practically speaking, not for everyone.

The test is expensive, and even if it predicts risk, it doesn’t help us stop the disease. What it helps with is planning.

It tells us:

  • Whether delivery may be needed soon
  • Whether steroids should be given
  • Whether magnesium sulfate is required
  • Whether the patient needs admission and close monitoring

It reduces complications, but does not prevent preeclampsia.

Where Can We Actually Help the Patient?
Uterine Artery Doppler – Very Important

This is where real prevention starts.

Done along with the NT-NB scan, it tells us about placental blood flow.

  • Low resistance → good trophoblastic invasion
  • High resistance → higher risk

Key values:

  • 11–14 weeks: Mean PI > 2.4
  • 20–24 weeks: Mean PI > 1.4

Higher values mean increased risk of:

  • Preeclampsia
  • Fetal growth restriction
Aspirin – But Timing Is Everything

If the uterine artery PI is high:

  • Start low-dose aspirin
  • Ideally 150 mg
  • Before 16 weeks

After 16 weeks, trophoblastic invasion is already complete, so starting late doesn’t provide much benefit.

Aspirin doesn’t completely prevent preeclampsia, but it can delay the onset and reduce the severity.

Other Early Predictors

Better prediction comes from combining:

  • Uterine artery PI
  • PLGF
  • Mean arterial pressure (MAP)

If MAP > 90 in early pregnancy, future risk increases.

High-Risk Patients Need Extra Attention

Some women need close monitoring right from the first trimester:

  • Previous preeclampsia or eclampsia
  • History of abruption or unexplained stillbirth
  • Chronic kidney disease
  • Diabetes
  • Autoimmune disorders like SLE

These patients benefit the most from early aspirin and strict surveillance.

What About the Future?

Many new markers are being studied:

  • Placental protein 13
  • ADAM-12
  • Soluble endoglin
  • Micro-RNAs

There are also drugs under research:

  • Sildenafil
  • Statins
  • Metformin

At present, aspirin is all we have. But in the future, safer drugs may help us actually prevent, not just predict, preeclampsia.

Final Thoughts

Right now, our focus should be:

  • Early screening
  • Identifying high-risk women
  • Starting aspirin on time
  • Close maternal and fetal monitoring

Prediction helps, but prevention is the real goal. We’re not there yet — but we’re getting closer.

Subscribe to the Conceptual OBG YouTube channel for more insightful sessions.

Share

Dr. Aditya Nimbkar

Previous Year Recall: MCQs on Medical Disorders in Pregnancy Insights from Dr. Aditya Nimbkar

0
0

Estimated reading time: 4 minutes

Medical disorders in pregnancy are a high-yield area for exams like NEET SS, INI-CET, and DNB, yet many questions are misunderstood because aspirants focus only on the final answer rather than the reasoning behind it. In this MCQ discussion session, Dr. Aditya Nimbkar breaks down multiple previous-year recall questions, explaining not just what the correct answer is, but why the other options are incorrect.

This blog summarises the key learning points from the session in a structured, exam-oriented format.

1. Magnesium Sulfate for Fetal Neuroprotection
What Is the Optimal Timing?

One of the most frequently asked MCQs revolves around magnesium sulfate (MgSO₄) use for fetal neuroprotection before preterm birth.

Key Concept

Magnesium sulfate is not routinely given to all women in preterm labour. Its use is selective and evidence-based.

Why Magnesium Sulfate?

Magnesium sulfate is preferred in pregnancy over other antiepileptics because of its broad neuroprotective action. It works through multiple mechanisms:

  • A – Adenosine potentiation → neuronal relaxation
  • B – GABA-B receptor activation → inhibitory neurotransmission
  • C – Calcium channel blockade
  • D – NMDA receptor inhibition
  • E – Glutamate inhibition (reduces excitotoxicity)

Together, these actions reduce neuronal excitability in both the mother and the fetus.

Why Is This Important for Preterm Babies?

Extremely preterm neonates are prone to:

  • Electrolyte imbalances
  • Germinal matrix hemorrhage
  • Neonatal seizures

Each seizure episode increases the risk of hypoxic brain injury, which magnesium sulfate helps prevent.

Exam-Oriented Answer
  • Indication: Imminent preterm birth
  • Gestational age: Up to 32 weeks (as per NICE guidelines)
  • Minimum duration: At least 4 hours before delivery
  • Maximum duration: 24 hours only

Repeat or rescue courses are not recommended.

Dose (Similar to Zuspan Regimen)
  • Loading dose: 4 g IV
  • Maintenance: 1 g/hour IV infusion
  • No intramuscular injections
Why Not Give It Repeatedly?

Excess magnesium:

  • Displaces calcium from receptors
  • Can cause fetal osteopenia
  • May lead to neonatal respiratory depression

Hence, one single course is sufficient.

2. Safest Antipsychotic Drug in Pregnancy (ACOG)

Psychiatric disorders like schizophrenia are not uncommon in pregnancy, making this a high-yield MCQ area.

Neonatal Adaptation Syndrome – A Must-Know Concept

Antipsychotic drugs can cause:

  • Poor neonatal tone
  • Poor feeding
  • Jitteriness
  • Extrapyramidal symptoms
  • Respiratory distress

This constellation is known as Neonatal Adaptation Syndrome.

Safest Antipsychotic Drugs

According to ACOG and RCOG:

Safest option:

  • Haloperidol (best safety data)

Other acceptable options:

  • Chlorpromazine
  • Olanzapine
  • Quetiapine
  • Risperidone
Important Clinical Pearl

Second-generation antipsychotics like olanzapine and quetiapine can worsen insulin resistance, increasing the risk of gestational diabetes mellitus (GDM).

What to do?
  • Perform OGTT at 24–28 weeks
  • Repeat OGTT at 32–36 weeks
Drugs to Avoid
  • Clozapine
  • Lithium
Breastfeeding Tip (Very Exam-Relevant)
  • Peak drug levels occur 1–2 hours after dosing
  • Advise mothers to avoid breastfeeding for 2–3 hours after taking the drug

This simple dose-spacing reduces neonatal side effects.

3. CNS Disorder That Worsens During Pregnancy
Trick in the Question

The worsening is not due to hormones, but due to immunological changes.

Immunological Shift in Pregnancy
  • Th1 → Th2 dominance
  • Increased humoral immunity
  • Reduced cell-mediated immunity
Correct Answer: Myasthenia Gravis
  • Antibody-mediated disease
  • Pregnancy increases antibody production
  • Leads to worsening neuromuscular weakness
Why Not the Others?
  • Multiple Sclerosis: Cell-mediated → fewer relapses in pregnancy
  • Parkinson’s Disease: Symptoms may worsen due to drug dilution but improve with dose adjustment
  • Epilepsy: Unpredictable (40% improve, 30% worsen, 30% unchanged)
4. GI Disorder That Does Not Worsen in Pregnancy

Progesterone relaxes smooth muscles and sphincters, leading to:

  • GERD (↓ LES tone)
  • Constipation (↓ peristalsis)
  • Gallstones (biliary stasis)
Correct Answer: Inflammatory Bowel Disease (IBD)
  • Ulcerative colitis
  • Crohn’s disease

These do not worsen physiologically during pregnancy.

Management of IBD in Pregnancy – High-Yield Points
Safe Drugs
  • Sulfasalazine (5-ASA)
  • Corticosteroids
  • Allopurinol
  • Anti-TNF agents (Infliximab, Adalimumab) → only till 24 weeks

Sulfasalazine causes folate trapping → Give 5 mg folic acid daily

Drugs to Avoid
  • Methotrexate
  • Tofacitinib

Methotrexate remains in tissues for months — avoid conception for at least 6 months

Crohn’s Disease and Mode of Delivery
  • Perianal Crohn’s disease → No episiotomy
  • Risk of deep perineal tears
  • Elective Caesarean Section is preferred
Key Takeaway for Exams

This session reinforces one crucial rule for medical exams:

Understanding the “why” behind an answer is more important than memorising the answer itself.

Approach MCQs conceptually, link physiology with clinical practice, and the guidelines will automatically make sense.Subscribe to Conceptual OBG for more insightful sessions to help you during your residency.

Share